Fluocinonide

Spécifications

356-12-7Numéro CAS

206-597-6Numéro CE

[2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetateNom IUPAC

C26H32F2O7Formule chimique

494.5 g/molMasse molaire

fluocinonide; 356-12-7; Lidex; Fluocinolide; Vanos; LIDEX-E; Fluocinonide Emulsified Base; Fluocinonidum; Fluocinolone acetonide 21-acetate; Fluocinonida; DTXSID8045307; 2W4A77YPAN; NSC-101791; DTXCID6025307; Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-; Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone, 21-acetate; Fluocinonide FAPG; Lidemol; 2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl acetate; Tiamol; Metosyn fapg; Fluocinol Pak; Fluovix Plus; NSC101791; 2-((1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-8-yl)-2-oxoethyl acetate; FAPG, Fluocinonide; RefChem:55210; C05AA11; D07AC08; Fluocinolone Acetonide 21 Acetate; Acetonide 21-Acetate, Fluocinolone; Fluocinonide Topical Solution USP, 0.05%; fluocinonide cream, silicone roll, self-adhesive wrap; (6alpha,11beta,16alpha)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione; 206-597-6; 6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione 21-acetate; Fluocinolone acetonide acetate; Fluocinolide acetate; Fluonex; Fluocinonidum [INN-Latin]; Fluocinonido [INN-Spanish]; Lidex E; Fluocinonide(Vanos); C26H32F2O7; Lonide; MLS000028476; 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone, 21-acetate; Lyderm; 2-((2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate; Fluocinonido; SMR000058331; MFCD00079302; Fluocinonide [USAN:BAN:INN:JAN]; Vanos (TN); EINECS 206-597-6; LIDEX (TN); UNII-2W4A77YPAN; NSC 101791; oethyl acetate; NCGC00016436-01; CAS-356-12-7; Prestwick_1066; Fluocinonide (Vanos); Fluocinonide [USAN:USP:INN:BAN:JAN]; Fluocinonide (Standard); Opera_ID_1780; Prestwick0_000774; Prestwick1_000774; Prestwick2_000774; Prestwick3_000774; FLUOCINONIDE [MI]; FLUOCINONIDE [INN]; FLUOCINONIDE [JAN]; FLUOCINONIDE [USAN]; SCHEMBL4262; CHEMBL1501; FLUOCINONIDE [VANDF]; BSPBio_000848; FLUOCINONIDE [MART.]; Pregna-1,4-diene-3,20-dione, 6-alpha, 9-difluoro-11-beta,16-alpha,17,21-tetrahydroxy-, cyclic17-acetal with acetone, 21-acetate; FLUOCINONIDE [USP-RS]; FLUOCINONIDE [WHO-DD]; SPBio_002787; BPBio1_000934; CHEBI:5109; GTPL7078; orb1300712; Fluocinonide (JP18/USP/INN); HY-B0485R; Fluocinonide, >=98% (HPLC); MSK2244; WJOHZNCJWYWUJD-IUGZLZTKSA-N; FLUOCINONIDE [ORANGE BOOK]; HMS1570K10; HMS2097K10; HMS2234H04; HMS3259N05; HMS3714K10; FLUOCINONIDE [USP IMPURITY]; FluocinonideLidex, Metosyn, Topsyn; HY-B0485; PREGNA-1,4-DIENE-3,20-DIONE, 21-(ACETYLOXY)-6,9-DIFLUORO-11-HYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-, (6.ALPHA.,11.BETA.,16.ALPHA.)-; Tox21_110438; EBC-27229; MSK2244-100A; s2608; AKOS015896516; MSK2244-1000A; Tox21_110438_1; AC-2071; CCG-220774; DB01047; FF08245; NC00621; NCGC00022398-03; NCGC00022398-05; NCGC00022398-14; BS-17093; DA-53244; NS00001330; T6502; C07007; D00325; EN300-19736975; SR-01000003097; Q5462791; SR-01000003097-3; BRD-K57886322-001-03-4; BRD-K57886322-001-12-5; FLUOCINOLONE ACETONIDE IMPURITY M [EP IMPURITY]; Fluocinolone acetonide acetate Solution in Acetonitrile, 1000ug/mL; Fluocinolone acetonide acetate Solution in Acetonitrile, 100ug/mL; Fluocinolone Acetonide EP Impurity M; Fluocinolone Acetonide Acetate; Fluocinonide, United States Pharmacopeia (USP) Reference Standard; [2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxo-ethyl] acetate; [2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate; 2-((2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-ox; 2-[(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl acetateSynonymes